Stacy Ehrlich draws on more than 25 years of experience to counsel her clients in the pharmaceutical, food, dietary supplement, tobacco, cosmetic, and medical device industries on regulatory and advertising law matters. In particular, Stacy provides practical, creative, and strategic advice to help clients achieve their business goals in compliance with laws and regulations implemented and enforced by the U.S. Food and Drug Administration (FDA), U.S. Department of Agriculture (USDA), Federal Trade Commission (FTC), Consumer Product Safety Commission (CPSC), and related federal, state, and local agencies. These matters include rulemaking and guidance development proceedings, premarket submissions, enforcement actions, legal challenges to agency action, advertising and labeling copy and claim substantiation, and expert due diligence.

Stacy serves as outside counsel for the Coalition of Independent Tobacco Manufacturers of America (CITMA) and the Coalition of Manufacturers of Smoking Alternatives (CMSA) and has been extensively involved FDA’s regulation of tobacco and nicotine products since the early legislative process of the Family Smoking Prevention and Tobacco Control Act.

A prolific author and speaker, Stacy is frequently called upon to educate others on topics of food and drug law, including OTC drug, cosmetic, and dietary supplement labeling and marketing and nicotine and tobacco product regulation and enforcement. She has also regularly authored chapters in the Food and Drug Law Institute (FDLI) publications, Food and Drug Law & Regulation, How to Work with the FDA, and Top 20 Food and Drug Cases & Cases to Watch.

Stacy has served on the Board of Directors of FDLI and has consistently been recognized for excellence in FDA Law by The Best Lawyers in America© and Super Lawyers©.

Prior to joining KKB, Stacy clerked for the Honorable Alexander B. Denson in the United States District Court of the Eastern District of North Carolina and practiced food and drug law at a large DC-based international law firm.